Filing Details

Accession Number:
0001209191-18-041074
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 16:25:08
Reporting Period:
2018-06-29
Accepted Time:
2018-07-03 16:25:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197032 F Ian Smith C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-29 23,375 $131.89 70,074 No 4 M Direct
Common Stock Disposition 2018-06-29 4,741 $165.22 65,333 No 4 S Direct
Common Stock Disposition 2018-06-29 18,634 $166.57 46,699 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-06-29 23,375 $0.00 23,375 $131.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,625 2025-07-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,306 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $165.22 (range $165.00 to $165.89).
  3. Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $166.57 (range $166.38 to $166.67).
  5. The option vests in 16 quarterly installments from 7/21/2015.